
Minnesota leaders react to Biden's prostate cancer diagnosis
Former president Joe Biden and his family say they're reviewing treatment options after he was diagnosed with an aggressive form of prostate cancer that has spread to his bones.
In a statement, the Biden family says the diagnosis came after doctors found a nodule on his prostate when he was seen for increased urinary symptoms.
Biden's advanced age presents a challenge, but even so, cancer doctors say there are effective treatments available.
In a statement, the Biden family says the cancer "appears to be hormone-sensitive which allows for effective management."
Biden's announcement comes as a new book detailing concerns over his health towards the end of his time in office is set to be released on Tuesday.
Walz, other Minnesota leaders react
Leaders from all over the world, including right here in Minnesota, are sending well wishes to the former president after his announcement.
Former Democratic vice presidential nominee and Minnesota Gov. Tim Walz said on X, "Gwen and I are praying for President Biden and his family. A truly decent man and a friend. We're wishing him all the best."
On the other side of the aisle, House Majority Whip Tom Emmer, Minnesota's highest-ranking Republican, said, "Jacquie and I are praying for former President Joe Biden and his family during this difficult time, and we wish him a full and speedy recovery."
Both of Minnesota's U.S. senators offered their support for Biden.
"Praying for President Biden and his entire family." Sen. Amy Klobuchar said. "Joe is a fighter who has shown strength and grit throughout his life, and I know he'll bring that same spirit to this fight with cancer."
"To our friend Joe Biden — Archie and I wish you the best as you take care of yourself," Sen. Tina Smith said. "Many families deal with cancer, and you have done so much to help them. Now we can support you and yours."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Chicago Tribune
23 minutes ago
- Chicago Tribune
What is the CBO? A look at the small office inflaming debate over President Donald Trump's tax bill
WASHINGTON — A small government office with some 275 employees has found itself caught in the political crossfire as Congress debates President Donald Trump's 'one big beautiful bill.' The Congressional Budget Office has projected that the legislation would increase federal deficits by about $2.4 trillion over 10 years. That's a problem for a Republican Congress that has spent much of the past four years criticizing former President Joe Biden and Democrats for the nation's rising debt levels. The White House and Republican leaders in Congress are taking issue with CBO's findings. They say economic growth will be higher than the office is projecting, resulting in more revenue coming into government coffers. Meanwhile, Democrats are touting CBO's findings as evidence of the bill's failings. President Donald Trump tax bill will add $2.4 trillion to the deficit and leave 10.9 million more uninsured, CBO saysHere's a look at the office at the center of Washington's latest political tug-of-war. Lawmakers established the Congressional Budget Office more than 50 years ago to provide objective, impartial analysis to support the budget process. The CBO is required to produce a cost estimate for nearly every bill approved by a House or Senate committee and will weigh in earlier when asked to do so by lawmakers. It also produces a report each Congress on how to reduce the debt if lawmakers so choose with each option including arguments for or against. Plus, it publishes detailed estimates when presidents make proposals that would affect mandator spending, which includes programs such as Social Security and Medicare. Lawmakers created the office to help Congress play a stronger role in budget matters, providing them with an alternative to the Office of Management and Budget, which is part of a Republican or Democratic administration, depending upon the president in office. CBO hires analysts based on their expertise, not political affiliation. Staff is expected to maintain objectivity and avoid political influence. In evaluating potential employees, the CBO says that for most positions it looks at whether that person would be perceived to be free from political bias. Like other federal employees, the CBO's staff is also prohibited from making political contributions to members of Congress. The CBO's director, Phillip Swagel, served in former Republican President George W. Bush's administration as an economic adviser and as an assistant secretary at the Treasury Department. The stakes are incredibly high with Republicans looking to pass their massive tax cut and immigration bill by early July. Outside groups, Democrats and some Republicans are highlighting CBO's analysis that the bill will increase federal deficits by about $2.4 trillion over 10 years and leave 10.9 million more people uninsured in 2034. Republicans spent much of Biden's presidency focused on curbing federal deficits. They don't want to be seen as contributing to the fiscal problem. GOP lawmakers say the CBO isn't giving enough credit to the economic growth the bill will create, to the point where it would be deficit-neutral in the long run, if not better. 'The CBO assumes long-term GDP growth of an anemic 1.8% and that is absurd,' said White House press secretary Karoline Leavitt. 'The American economy is going to boom like never before after the 'One Big, Beautiful Bill' is passed.' Republicans began taking issue with the CBO even before Trump and the current Congress were sworn into office. 'CBO will always predict a dark future when Republicans propose tax relief – but the reality is never so dire,' Rep. Jason Smith, the Republican chairman of the House Ways and Means Committee, said in a December news release. Recently, House Speaker Mike Johnson has been taking digs at the office. 'The CBO is notorious for getting things WRONG,' he said in a Facebook post. In April 2018, CBO said that tax receipts would total $27 trillion from fiscal years 2018 to 2024. Receipts came in about $1.5 trillion higher than the CBO projected. Republicans have seized on that discrepancy. But the numbers don't tell the whole story. Some of the criticism of the CBO ignores the context of a global pandemic as the federal government rushed to prop the economy up with massive spending bills under both Trump and Biden. In a blog post last December, Swagel pointed out three reasons for the higher revenues: The primary reason was the burst of inflation that began in March 2021 as the country was recovering from COVID. That burst of inflation, he said, led to about $900 billion more in revenue. There was also an increase in economic activity in 'the later years of the period' adding $700 billion. Also, new tariffs added about $250 billion, with other legislation partially offsetting those three factors.


Gizmodo
25 minutes ago
- Gizmodo
Smoking Weed and Eating Edibles Share This Surprising Health Risk
A new study has found a startling link between chronic cannabis use and increased risk of cardiovascular disease—regardless of whether you smoke it or consume edibles. The finding challenges commonly held beliefs about the health impacts of tetrahydrocannabinol (THC), which many see as a relatively harmless drug—especially when ingested. The study, published Wednesday, May 28 in the journal JAMA Cardiology, found that THC smokers suffer from significantly worse artery function than non-users. They observed the same effect in edible consumers, though their arteries were not as severely affected. In either case, vascular function was reduced by roughly half compared to those who do not use cannabis, according to a statement from the University of California, San Francisco. 'Scientifically, this THC result is really interesting but boy does it screw up the public health messaging,'' co-author Matt Springer, a cardiovascular researcher at UCSF, reportedly said to lead author and UCSF physician-scientist Leila Mohammadi when he saw the data. These results add to a growing body of evidence that suggests long-term weed use can lead to cardiovascular damage and life-threatening events such as heart attacks and strokes, though experts still lack consensus on its precise impacts. A 2024 study published in the Journal of the American Heart Association found that people who consume cannabis daily had a 25% increased risk of heart attack and a 42% increased risk of stroke compared to non-users. For this new study, researchers investigated how cannabis impacts vascular function. To isolate the effects of chronic cannabis use, they recruited 55 otherwise healthy adults aged 18 to 50 who did not use any form of nicotine and were not frequently exposed to secondhand smoke. These participants were sorted into three groups: marijuana smokers, edible users, and non-users. Those in the two cannabis user groups reported taking the drug at least three times per week, either exclusively through smoking or edibles. To assess the participants' vascular function, the researchers measured dilation of the brachial artery—located in the upper arm—to determine whether it could properly expand in response to increased blood flow. To that end, they used an inflatable forearm cuff to briefly block blood flow to the artery, then used ultrasound to measure its diameter before and after inflating the cuff. Matt Springer, a cardiovascular researcher at UCSF whose lab led the study, told Live Science that his test offers a 'window into the future.' When blood vessels cannot fully dilate, he said, the risk of heart attack and other poor cardiovascular outcomes increases. Participants who did not consume cannabis showed an average vessel dilation—represented as the percent change from the baseline measurement of artery diameter—of 10.4%. This value was significantly reduced among weed smokers and edible users, who showed an average vessel dilation of 6.0% and 4.6%, respectively. For reference, average values for brachial artery dilation in healthy individuals typically range from 8.0% to 15%. In a previous study, Springer's lab found similarly reduced levels of vessel dilation among e-cigarette and cigarette smokers. To better understand how THC causes this change, the researchers ran lab tests to determine how endothelial cells—which form the linings of blood vessels and release nitric oxide to trigger dilation—responded to the participants' blood samples. These tests revealed that the blood of chronic cannabis smokers inhibited nitric oxide production in the cells, which may explain why these participants showed reduced vessel dilation. This effect was not observed in edible consumers, however, suggesting that ingestible THC may impact arterial function via an entirely separate mechanism. Figuring out what that mechanism may be will require further research. What's more, subsequent studies will need to reproduce these findings in a larger population to validate the results. Within the last several years, cannabis use among U.S. adults has reached new heights, according to the NIH's National Institute on Drug Abuse. As such, investigating the health effects of THC is more important than ever before—especially as mounting evidence challenges perceptions of weed as a harmless high.


The Verge
28 minutes ago
- The Verge
Peter Thiel's Jeffrey Epstein connections.
Isn't it funny how all these tech and science men have ties to Epstein? I wonder why! Anyway, Epstein invested with Thiel's Valar Ventures — and that investment hasn't previously been disclosed. Guess what that means? 'There's a good chance much of the windfall will not go to any of the roughly 200 victims whom the disgraced financier abused when they were teenagers or young women.'